Of the 75 participants with obesity, 34 were hypertensive (~45%), 42 were insulin resistant or had diabetes (56%), 38 were dyslipidemic with disrupted lipid profile (~51%), and 46 had steatotic liver (~61%). This evidence concerns the gene INS and diabetes mellitus.